These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 2466394)

  • 21. Increased concentrations of the monoamine metabolites homovanillic acid and 5-hydroxyindoleacetic acid in lumbar and central CSF and of 3-methoxy-4-hydroxyphenylglycol in lumbar CSF after subarachnoid haemorrhage.
    von Holst H; Lindquist C; Sedvall G
    Acta Neurochir (Wien); 1985; 77(3-4):146-51. PubMed ID: 2416192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
    Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlations between aminergic metabolites simultaneously obtained from human CSF and brain.
    Stanley M; Traskman-Bendz L; Dorovini-Zis K
    Life Sci; 1985 Oct; 37(14):1279-86. PubMed ID: 2413327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoamine metabolites in ventricular CSF of children with posterior fossa tumors: correlation with tumor histology and cognitive functioning.
    Varela M; Alexiou GA; Liakopoulou M; Papakonstantinou E; Pitsouni D; Alevizopoulos GA
    J Neurosurg Pediatr; 2014 Apr; 13(4):375-9. PubMed ID: 24559277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism.
    Sher L; Oquendo MA; Li S; Huang YY; Grunebaum MF; Burke AK; Malone KM; Mann JJ
    Neuropsychopharmacology; 2003 Sep; 28(9):1712-9. PubMed ID: 12825091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    Yoshino K
    No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrospinal fluid monoamine metabolites in patients with infantile spasms.
    Silverstein F; Johnston MV
    Neurology; 1984 Jan; 34(1):102-5. PubMed ID: 6197678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CSF amine metabolites in depression.
    Reddy PL; Khanna S; Subhash MN; Channabasavanna SM; Rao BS
    Biol Psychiatry; 1992 Jan; 31(2):112-8. PubMed ID: 1371076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Individual differences in basal cisternal cerebrospinal fluid 5-HIAA and HVA in monkeys. The effects of gender, age, physical characteristics, and matrilineal influences.
    Raleigh MJ; Brammer GL; McGuire MT; Pollack DB; Yuwiler A
    Neuropsychopharmacology; 1992 Dec; 7(4):295-304. PubMed ID: 1282317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homovanillic acid and 5-hydroxyindoleacetic acid in the ventricular CSF of comatose patients with obstructive hydrocephalus.
    Inagawa T; Ishikawa S; Uozumi T
    J Neurosurg; 1980 May; 52(5):635-41. PubMed ID: 6154788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between abnormal brainstem auditory-evoked potentials and subnormal CSF levels of HVA and 5-HIAA in first-episode schizophrenic patients.
    Lindström LH; Wieselgren IM; Klockhoff I; Svedberg A
    Biol Psychiatry; 1990 Sep; 28(5):435-42. PubMed ID: 1698468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CSF monoamine metabolites and lethality of suicide attempts in depressed patients with alcohol dependence.
    Sher L; Oquendo MA; Grunebaum MF; Burke AK; Huang YY; Mann JJ
    Eur Neuropsychopharmacol; 2007 Jan; 17(1):12-5. PubMed ID: 16762535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of idebenone on monoamine metabolites in cerebrospinal fluid of patients with cerebrovascular dementia.
    Kawakami M; Itoh T
    Arch Gerontol Geriatr; 1989 May; 8(3):343-53. PubMed ID: 2475076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship of cerebrospinal fluid monoamine metabolites with clinical response to tetrahydroaminoacridine in patients with Alzheimer's disease.
    Alhainen K; Helkala EL; Reinikainen K; Riekkinen P
    J Neural Transm Park Dis Dement Sect; 1993; 5(3):185-92. PubMed ID: 7690228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetics of monoamine metabolites in baboons: overlapping sets of genes influence levels of 5-hydroxyindolacetic acid, 3-hydroxy-4-methoxyphenylglycol, and homovanillic acid.
    Rogers J; Martin LJ; Comuzzie AG; Mann JJ; Manuck SB; Leland M; Kaplan JR
    Biol Psychiatry; 2004 Apr; 55(7):739-44. PubMed ID: 15039003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoamines in the brain cerebrospinal fluid of facial pain patients.
    Bouckoms AJ; Sweet WH; Poletti C; Lavori P; Carr D; Matson W; Gamache P; Aronin N
    Anesth Prog; 1992; 39(6):201-8. PubMed ID: 7504420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variations in CSF monoamine metabolites according to the season of birth.
    Chotai J; Asberg M
    Neuropsychobiology; 1999; 39(2):57-62. PubMed ID: 10072660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
    Nilsson LK; Nordin C; Jönsson EG; Engberg G; Linderholm KR; Erhardt S
    J Psychiatr Res; 2007; 41(1-2):144-51. PubMed ID: 16434056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A study of clinical pictures and monoamine metabolism of Gilles de la Tourette syndrome].
    Takano K; Ishiguro T
    Seishin Shinkeigaku Zasshi; 1993; 95(1):1-29. PubMed ID: 7685527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
    Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
    Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.